Showing 1 - 2 results of 2 for search 'Laura Pisarsky', query time: 0.01s Refine Results
  1. 1
    The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models

    The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models by Dongli Liu, Cassandra J. Vandenberg, Patrizia Sini, Lorenz Waldmeier, Rosa Baumgartinger, Laura Pisarsky, Georg Petroczi, Gayanie Ratnayake, Clare L. Scott, Caroline E. Ford

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer

    A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer by Peter Jung, Stefan P. Glaser, Jing Han, Alexandra Popa, Laura Pisarsky, Ningping Feng, Antonia Geyer, Franziska Haderk, Donat Alpar, Christopher Bristow, Susanne Schmittner, Paula-Elena Traexler, Mikhila Mahendra, Birgit Poehn, Poojabahen Gandhi, Roberto Fiorelli, Sanket Awate, Nicole Budano, Florian Martin, Christoph Albrecht, Barbara Drobits-Handl, Sathanandam S. Anand, Srinath Kasturirangan, Francesca Trapani, Norbert Schweifer, Joseph R. Marszalek, Ulrike Tontsch-Grunt, Mark Pearson, Timothy P. Heffernan, Norbert Kraut, Christopher P. Vellano, Juan Manuel García-Martínez

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: